Dr. Wu Skincare Co., Ltd.

TPEX:6523 Stock Report

Market Cap: NT$6.8b

Dr. Wu Skincare Past Earnings Performance

Past criteria checks 5/6

Dr. Wu Skincare has been growing earnings at an average annual rate of 8.8%, while the Personal Products industry saw earnings growing at 7.8% annually. Revenues have been growing at an average rate of 5.8% per year. Dr. Wu Skincare's return on equity is 29.1%, and it has net margins of 36.5%.

Key information

8.8%

Earnings growth rate

8.8%

EPS growth rate

Personal Products Industry Growth13.9%
Revenue growth rate5.8%
Return on equity29.1%
Net Margin36.5%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Dr. Wu Skincare Co., Ltd.'s (GTSM:6523) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Mar 18
Dr. Wu Skincare Co., Ltd.'s (GTSM:6523) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Is Dr. Wu Skincare (GTSM:6523) Likely To Turn Things Around?

Feb 23
Is Dr. Wu Skincare (GTSM:6523) Likely To Turn Things Around?

Is Dr. Wu Skincare Co., Ltd. (GTSM:6523) A Smart Choice For Dividend Investors?

Feb 03
Is Dr. Wu Skincare Co., Ltd. (GTSM:6523) A Smart Choice For Dividend Investors?

If You Had Bought Dr. Wu Skincare's (GTSM:6523) Shares Five Years Ago You Would Be Down 66%

Dec 22
If You Had Bought Dr. Wu Skincare's (GTSM:6523) Shares Five Years Ago You Would Be Down 66%

Can Mixed Fundamentals Have A Negative Impact on Dr. Wu Skincare Co., Ltd. (GTSM:6523) Current Share Price Momentum?

Dec 04
Can Mixed Fundamentals Have A Negative Impact on Dr. Wu Skincare Co., Ltd. (GTSM:6523) Current Share Price Momentum?

Revenue & Expenses Breakdown

How Dr. Wu Skincare makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:6523 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,22744833111
30 Jun 241,22147832911
31 Mar 241,21148531910
31 Dec 231,1374253159
30 Sep 231,0884074588
30 Jun 231,0153622997
31 Mar 239443312907
31 Dec 229273402787
30 Sep 229503281458
30 Jun 221,0563512949
31 Mar 221,12632330210
31 Dec 211,10629630810
30 Sep 211,01474129211
30 Jun 2191370628011
31 Mar 2181969527411
31 Dec 2076566126611
30 Sep 2079121428512
30 Jun 2082617933812
31 Mar 2093918740712
31 Dec 191,01419245612
30 Sep 191,0668350211
30 Jun 191,0295850811
31 Mar 191,0075250910
31 Dec 189632550510
30 Sep 189387549110
30 Jun 189258647610
31 Mar 188938746111
31 Dec 179371274379
30 Sep 171,02820443310
30 Jun 171,10325742611
31 Mar 171,17431341012
31 Dec 161,15131240013
30 Sep 161,08330535713
30 Jun 161,04131233712
31 Mar 1695325833512
31 Dec 1586522831511
30 Sep 1581524429710
30 Jun 157652372559
31 Mar 156952472029
31 Dec 146632391908
31 Dec 135651891604

Quality Earnings: 6523 has high quality earnings.

Growing Profit Margin: 6523's current net profit margins (36.5%) are lower than last year (37.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 6523's earnings have grown by 8.8% per year over the past 5 years.

Accelerating Growth: 6523's earnings growth over the past year (10.2%) exceeds its 5-year average (8.8% per year).

Earnings vs Industry: 6523 earnings growth over the past year (10.2%) exceeded the Personal Products industry -1%.


Return on Equity

High ROE: 6523's Return on Equity (29.1%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/19 18:46
End of Day Share Price 2024/12/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Wu Skincare Co., Ltd. is covered by 5 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Pinghan HsiehCapital Securities Corporation
Zhennan LeeJih Sun Securities Investment Consulting Co., Ltd.
Hsiu Chi LinMasterlink Securities Corp.